Suppr超能文献

从指南到临床实践:医院及地理特征对急性冠脉综合征治疗时间趋势的影响。全球急性冠状动脉事件注册研究(GRACE)。

From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE).

作者信息

Fox Keith A A, Goodman Shaun G, Anderson Frederick A, Granger Christopher B, Moscucci Mauro, Flather Marcus D, Spencer Frederick, Budaj Andrzej, Dabbous Omar H, Gore Joel M

机构信息

Department of Cardiology, The Royal Infirmary of Edinburgh, University of Edinburgh, Edinburgh EH3 9YW, Scotland, UK.

出版信息

Eur Heart J. 2003 Aug;24(15):1414-24. doi: 10.1016/s0195-668x(03)00315-4.

Abstract

AIMS

The extent to which hospital and geographic characteristics influence the time course of uptake of evidence from key clinical trials and practice guidelines is unknown. The gap between evidence and practice is well recognized but the factors influencing this disjunction, and the extent to which such factors are modifiable, remain uncertain.

METHODS AND RESULTS

Using chronological data from the GRACE registry (n=12666, July 1999 to December 2001), we test the hypothesis that hospital and geographic characteristics influence the time course of uptake of evidence-based guideline recommendations for acute coronary syndromes (ACS) with and without ST elevation. Certain therapies were widely adopted in both ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) patients (aspirin >94% of all patients; beta-blockers 85-95%) and changed only modestly over time. Significant increases in the use of low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors occurred in STEMI and NSTEMI patients in advance of published practice guidelines (September/November 2000) with marked geographical differences. The highest use of LMWH was in Europe in NSTEMI (86.8%) and the lowest in the USA (24.0%). Contrasting geographical variations were seen in the use of percutaneous coronary intervention (PCI) in NSTEMI: 39.5% USA, 34.6% Europe, 33.5% Argentina/Brazil, 25.0% Australia/New Zealand/Canada (July-December 2001). Theuse of PCI was more than five times greater in hospitals with an on-site catheterization laboratory compared to centres without these facilities, and geographic differences remained after correction for available facilities.

CONCLUSIONS

Hospital and geographical factors appear to have a marked influence on the uptake of evidence-based therapies in ACS management. The presentation and publication of major international guidelines was not associated with a measurable change in the temporal pattern of practice. In contrast, antithrombotic and interventional therapies changed markedly over time and were profoundly influenced by hospital and geographic characteristics.

摘要

目的

医院和地理特征对关键临床试验和实践指南证据采用的时间进程影响程度尚不清楚。证据与实践之间的差距已得到充分认识,但影响这种脱节的因素以及这些因素可改变的程度仍不确定。

方法与结果

利用GRACE注册研究(1999年7月至2001年12月,n = 12666)的时间顺序数据,我们检验了以下假设:医院和地理特征会影响急性冠脉综合征(ACS)伴或不伴ST段抬高时基于证据的指南推荐的采用时间进程。某些治疗方法在ST段抬高型心肌梗死(STEMI)和非ST段抬高型心肌梗死(NSTEMI)患者中均被广泛采用(阿司匹林在所有患者中的使用率>94%;β受体阻滞剂为85 - 95%),且随时间变化仅略有改变。在已发表实践指南(2000年9月/11月)之前,STEMI和NSTEMI患者中低分子量肝素和糖蛋白IIb / IIIa抑制剂的使用显著增加,且存在明显的地理差异。NSTEMI患者中低分子量肝素使用率最高的是欧洲(86.8%),最低的是美国(24.0%)。NSTEMI患者经皮冠状动脉介入治疗(PCI)的使用存在明显的地理差异:美国为39.5%,欧洲为34.6%,阿根廷/巴西为33.5%,澳大利亚/新西兰/加拿大为25.0%(2001年7月至12月)。与没有这些设施的中心相比,有现场导管实验室的医院PCI使用率高出五倍多,校正可用设施后地理差异仍然存在。

结论

医院和地理因素似乎对ACS管理中基于证据的治疗方法的采用有显著影响。主要国际指南的发布和公布与实践时间模式的可测量变化无关。相比之下,抗血栓和介入治疗随时间变化显著,且受到医院和地理特征的深刻影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验